Osteoporosis International

, Volume 14, Issue 4, pp 334–338 | Cite as

Contribution of clinical risk factors to bone density-based absolute fracture risk assessment in postmenopausal women

Original Article

Abstract

Hip fractures are independently associated with advancing age, specific clinical risk factors (CRFs), and low bone mineral density (BMD). The use of BMD T-scores for quantifying fracture risk ignores the contribution of age and CRFs. We previously developed a mathematical model of absolute hip fracture risk that incorporates patient age, BMD, and the results of eleven specific CRFs. The purpose of this study was to compare the contribution of an approach to fracture risk stratification using the full model (age, CRFs and BMD) with that of a unidimensional BMD-only model. We selected 213 consecutive postmenopausal females (mean age 65.3, range 50–87.9) with CRF data referred for BMD assessment of fracture risk. Absolute hip fracture risk (over the next 5 years and remaining lifetime) was estimated using both the full and BMD-only models. The mean ratio of absolute hip fracture risks (BMD-only/full model) derived for each patient was 0.8 (95% CI, 0.16–4.0) for hip fracture in the next 5 years and 1.1 (CI, 0.1–7.6) for remaining lifetime. The wide confidence intervals indicate a large contribution of age and CRFs to fracture risk stratification. Categorization of women as "high risk" was frequently discordant for the two models. One-half of the women designated "high risk" under the full model were classified as "low risk" based upon BMD alone. In conclusion, we have shown that a multidimensional approach to hip fracture risk stratification is feasible, and greatly modifies risk stratification based on BMD alone.

Keywords

Bone densitometry Fracture risk Osteoporosis  

References

  1. 1.
    Miller PD, Zapalowski C, Kulak CA (1999) Bone densitometry: the best way to detect osteoporosis and to monitor therapy. J Clin Endocrinol Metab 84(6):1867–1871Google Scholar
  2. 2.
    NIH Consensus Development Panel (2001) NIH Consensus Development Panel of Osteoporosis Prevention, Diagnosis and Therapy; Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785–795Google Scholar
  3. 3.
    Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259Google Scholar
  4. 4.
    Heaney RP (1998) Bone mass, bone fragility, and the decision to treat. JAMA 280:2119–2120Google Scholar
  5. 5.
    Black DM (1999) The role of clinical risk factors in the prediction of future fracture risk. J Clin Densitometry 2(4):361–362Google Scholar
  6. 6.
    Mosca L (1999) Absolute risk assessment in the clinical setting. Am J Med 107 (2A):7S-9SGoogle Scholar
  7. 7.
    Kanis JA, Glüer C-C, for the Committee of Scientific Advisors, International Osteoporosis Foundation (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporosis Int 11:192–202Google Scholar
  8. 8.
    Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27(5):585–590Google Scholar
  9. 9.
    Leslie WD, Metge C, Salamon EA, Yuen CK (2003) Bone mineral density testing in healthy postmenopausal women: The role of clinical risk factor assessment in determining fracture risk. J Clin Densitometry (in press)Google Scholar
  10. 10.
    Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307-310Google Scholar
  11. 11.
    Alderman MH (1996) Absolute cardiovascular risk: the basis for deciding to treat. Am J Nephrol 16(3):182–189Google Scholar
  12. 12.
    Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V (1999) AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 34 (4):1348–1359Google Scholar
  13. 13.
    Grover SA, Dorais M, Paradis G, Fodor JG, Frohlick JJ, McPherson R, et al. (2000) Lipid screening to prevent coronary artery disease: a quantitative evaluation of evolving guidelines. CMAJ 163 (10):1263–1269Google Scholar
  14. 14.
    Fodor JG, Frolich JJ, Genest JJG Jr, McPherson PR, For the Working Group on Hypercholesterolemia and Other Dyslipidemias (2000) Recommendations for the management and treatment of dyslipidemia. CMAJ 162(10):1441–1447Google Scholar
  15. 15.
    Guidelines Subcommittee, World Health Organization–International Society of Hypertension (1999) Guidelines for the management of hypertension. J Hypertens 17(2):151–183Google Scholar
  16. 16.
    Development Committee of the National Osteoporosis Foundation (1998) Osteoporosis review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporosis Int 8(Suppl 4):S1-S88Google Scholar
  17. 17.
    Wainright SA, Phipps KR, Stone JV, et al. (2001) A large proportion of fractures in postmenopausal women occur with baseline bone mineral density T-score >-2.5. J Bone Miner Res 16(Suppl 1):S155Google Scholar
  18. 18.
    Close J, Ellis M, Hooper R, Glucksman E, Jackson S, Swift C (1999) Prevention of falls in the elderly trial (PROFET): a randomised controlled trial. Lancet 353(9147):93-97Google Scholar
  19. 19.
    Kannus P, Parkkari J, Niemi S, Pasanen M, Palvanen M, Jarvinen M, Vuori I (2000) Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med 343(21):1506–1513Google Scholar
  20. 20.
    Parker MJ, Gillespie LD, Gillespie WJ (2000) Hip protectors for preventing hip fractures in the elderly (Cochrane Review). Cochrane Database Syst Rev 4:CD001255Google Scholar
  21. 21.
    Black DM, Steinbuch M, Palermo L, Dargent-Molina P, Lindsay R, Hoseyni MS, Johnell O (2001) An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 12(7):519–528Google Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2003

Authors and Affiliations

  1. 1.Department of Medicine and Radiology (C5121)University of ManitobaWinnipegCanada
  2. 2.Faculty of PharmacyUniversity of ManitobaWinnipegCanada
  3. 3.Department of Nuclear MedicineSt. Boniface General HospitalWinnipegCanada

Personalised recommendations